Latest Trials

Systemic therapy trial

M16-106 : A Phase 1 Dose Escalation, Open-Label Study of Venetoclax in Combination With Navitoclax...

This phase I trial is combining two oral drugs (Venetoclax and Navitoclax) with chemotherapy in patients with Acute Lymphoblastic Leukaemia (ALL) or Lymphoblastic Lymphoma that has gotten worse or not responded to treatment

Status : Recruiting

Systemic therapy trial

An Open-Label, Multicenter, Phase I Trial Evaluating the Safety and Pharmacokinetics of...

This phase I trial is evaluating an intravenous drug (BFCR4350A) in patients with multiple myeloma, who have progressed or not responded to prior treatment

Status : Recruiting

Systemic therapy trial

GHSG HD21 : Treatment optimisation trial in the first-line treatment of advanced stage Hodgkin...

This phase III trial is comparing two 6-cycle chemotherapy treatments (BEACOPP and BrECADD) in the first-line treatment of advanced Hodgkin's Lymphoma

Status : Recruiting

Systemic therapy trial

PRIMULA : A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Of...

This phase III trial is combining two drugs (Pracinostat and Azacitidine) in patients with newly diagnosed Acute Myeloid Leukaemia (AML)

Status : Recruiting

Systemic therapy trial

Dynamic Ovarian : Circulating Tumour DNA as a Marker of Residual Disease and Response to Adjuvant...

This phase II/III trial is evaluating the process of using ctDNA (tumour-derived DNA) results as a way to tailor treatment (in this case, chemotherapy) in patients with Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Status : Recruiting

Systemic therapy trial

IMbrave150 : A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination With Bevacizumab...

This phase III trial is comparing two immunotherapy drugs (Atezolizumab and Bevacizumab) with an oral targeted therapy (Sorafenib) in the treatment of previously untreated locally advanced or metastatic hepatocellular (liver) cancer

Status : Recruiting

Systemic therapy trial

Imvoke10 : A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of...

This phase III trial is evaluating an immunotherapy drug (Atezolizumab) for the treatment of high-risk locally advanced head and neck cancer

Status : Recruiting

Systemic therapy trial

A Phase 1B Study Evaluating RO7082859 in Combination With Rituximab (R) or Obinutuzumab...

This phase I trial is combining a new intravenous drug (RO7082859) with an immunotherapy (Rituximab or Obinutuzumab) and chemotherapy (CHOP) treatment in patients with newly diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Status : Recruiting

Systemic therapy trial

Morpheus-TNBC : A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy...

This phase I/II trial is evaluating various immunotherapy based treatment combinations as a way of treating patients with a Triple Negative Breast Cancer (TNBC) that has spread to other parts of the body

Status : Recruiting

Systemic therapy trial

Javelin Chemotherapy Medley : A Multicenter, Open-label, Phase 1b/2 Study To Evaluate Safety And Efficacy Of Avelumab...

This phase I/II trial is evaluating the safety and effectiveness of an immunotherapy (Avelumab) when given in combination with a chemotherapy (gemcitabine / cisplatin) or another type of immunotherapy (pemetrexed / carboplatin) in the treatment of advanced cancer

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.